Jay A Berzofsky

USPTO Granted Patents = 49 (Patent Applications = 10)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 10 (Patent Applications = 11)

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 253(Granted Patents)

Company Filing History:

33 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

15 out of 1,215

The United States of America As Represented by the Department of Health

patents

3 out of 118

The University of Birmingham

patents

4. 1 out of 2,202

The United States of America As Represented by the Secretary of

patents

5. 1 out of 757

University of Connecticut

patents

6. 1 out of 600

Baylor College of Medicine

patents

where one patent can have more than one assignee

Years Active: 1989-2025

Loading Chart...

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268700 - 3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof (2025-04-08),

2. 12083448 - Purification and labeling of extracellular vesicles using a mixed mode resin composition (2024-09-10),

3. 11536719 - Molecular nanotags (2022-12-27),

4. 11266726 - Compositions and methods for the treatment of HER2-expressing solid tumors (2022-03-08),

5. 10876955 - Optical configuration methods for spectral scatter flow cytometry (2020-12-29),

6. 10286050 - Multi-epitope TARP peptide vaccine and uses thereof (2019-05-14),

7. 9517243 - Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity (2016-12-13),

8. 9474793 - Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus (2016-10-25),

9. 9421254 - Immunostimulatory combinations of TLR ligands and methods of use (2016-08-23),

10. 9394352 - Immunogenic POTE peptides and methods of use (2016-07-19),

11. 9206245 - Immunogenic peptides and methods of use for treating and preventing cancer (2015-12-08),

12. 9168291 - β-mannosylceramide and stimulation of NKT cell anti-tumor immunity (2015-10-27),

13. 8877914 - Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes (2014-11-04),

14. 8871902 - Immunogenic POTE peptides and methods of use (2014-10-28),

15. 8835613 - β-mannosylceramide and stimulation of NKT cell anti-tumor immunity (2014-09-16),

Title: The Innovative Journey of Jay A. Berzofsky

Introduction:

Jay A. Berzofsky, a distinguished inventor hailing from Bethesda, MD, has made significant contributions to the field of innovation with his groundbreaking ideas and inventions.

Latest Patents:

Jay A. Berzofsky's latest patents include cutting-edge technologies in the fields of biotechnology and medical devices, showcasing his commitment to advancing healthcare solutions through innovation.

Career Highlights:

Throughout his illustrious career, Jay A. Berzofsky has been recognized for his pioneering work in developing novel approaches to address complex challenges. His innovative spirit has led to the creation of patents that have revolutionized industries.

Collaborations:

Jay A. Berzofsky has collaborated with leading research institutions and universities to further his inventions, demonstrating his dedication to pushing the boundaries of what is possible through strategic partnerships and collaborations.

Conclusion:

In conclusion, Jay A. Berzofsky's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions continue to inspire the next generation of innovators to think boldly and create solutions that shape the future.

This text is generated by artificial intelligence and may not be accurate.